Pure Global

XGEVA 120 MG SC SOLUTION FOR INJECTION, 1 PIECE - Turkey License 4744e4d4a30e592df6502acabce7cb0d

Access comprehensive regulatory information for XGEVA 120 MG SC SOLUTION FOR INJECTION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 4744e4d4a30e592df6502acabce7cb0d with license number 2022/469and contains active ingredient Denosumab . The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
4744e4d4a30e592df6502acabce7cb0d
License Details
Turkey SFDA License: 4744e4d4a30e592df6502acabce7cb0d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

XGEVA 120 MG SC SOLUTION FOR INJECTION, 1 PIECE
TR: XGEVA 120 MG SC ENJEKSİYONLUK ÇÖZELTİ, 1 ADET
Pharmaceutical Product

License Details

4744e4d4a30e592df6502acabce7cb0d

2022/469

8699862770125

M05BX04

License Holder Information

Active Ingredient

Denosumab

License Information

Aug 23, 2022